- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Biliary colic.
Displaying page 1 of 1.
EudraCT Number: 2004-001069-17 | Sponsor Protocol Number: CSPI135ZDE04 | Start Date*: 2004-09-16 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: A double-blind, active-controlled, randomized, multicenter, parallel-group 2 day comparison of 1000 mg propyphenazone / 80 mg codeine (applied as two suppositories) combination therapy versus a 100... | |||||||||||||
Medical condition: acute, at least moderate to severe biliary or urogenital pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003174-89 | Sponsor Protocol Number: AUDC/11 | Start Date*: 2013-01-28 | |||||||||||
Sponsor Name:Enrique De Madaria Pascual | |||||||||||||
Full Title: Ursodeoxycholic acid in the secondary prophylaxis of acute biliary pancreatitis: pilot clinical trial randomized double-blind. | |||||||||||||
Medical condition: Gallstone Dissolution | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005919-24 | Sponsor Protocol Number: C/399/2002 | Start Date*: 2006-07-19 |
Sponsor Name:Dr. Falk Pharma Portugal | ||
Full Title: Randomized, multicenter, double blind, placebo controlled trial, for the evaluation of the efficacy and tolerability of ursodeoxycholic acid on the dissolution of cholesterol gallstones (<15mm) aft... | ||
Medical condition: Randomized multicenter double blind, placebo controlled trial, for the evaluation of the efficacy and tolerability of UDCA on the dissolution of cholesterol gallstones (<15mm) after 18 months of th... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000904-36 | Sponsor Protocol Number: IBS-DOTIG-ECM-2202 | Start Date*: 2022-05-09 | |||||||||||
Sponsor Name:Instituto de Investigación Biomédica de Salamanca | |||||||||||||
Full Title: Randomized clinical trial to evaluate the dose and administration time of indocyanine green in near-infrared fluorescent cholangiography during laparoscopic cholecystectomy. | |||||||||||||
Medical condition: Laparoscopic cholecystectomy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000357-54 | Sponsor Protocol Number: UniversityHospitalGrenoble | Start Date*: 2007-07-08 |
Sponsor Name:UniversityHospitalGrenoble | ||
Full Title: Chemotherapy of first line "reinforced" for cancers of the colonist and the rectum with hepatic and/or pulmonary metastases potentially résécables: Strong association FOLFIRI and ERBITUX | ||
Medical condition: cancers of the colonist and the rectum | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003353-24 | Sponsor Protocol Number: Hx-CD4-110 | Start Date*: 2007-04-25 | ||||||||||||||||
Sponsor Name:TenX Biopharma, Inc., | ||||||||||||||||||
Full Title: Open-label, Dose escalation, followed by Open-label, Single Arm, Multi-center Clinical Trial of HuMax-CD4, a Fully Human Monoclonal Anti-CD4 Antibody, in Patients with Mycosis Fungoides (stage IB-I... | ||||||||||||||||||
Medical condition: Refractory Mycosis Fungoides (stage IB-IVB) and Sézary Syndrome. The study population will be patients who are refractory to or intolerant to at least two prior therapies, one being Targretin, the... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) FR (Completed) IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004186-83 | Sponsor Protocol Number: RZ358-606 | Start Date*: 2017-04-11 | ||||||||||||||||||||||||||
Sponsor Name:Rezolute, Inc. | ||||||||||||||||||||||||||||
Full Title: An Open-Label Multiple-Dose Study of RZ358 in Patients with Congenital Hyperinsulinism | ||||||||||||||||||||||||||||
Medical condition: Hypoglycemia associated with congenital hyperinsulinism | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) DK (Completed) BG (Completed) ES (Ongoing) | ||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
